The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery
Open accessAbstract
Most drug therapies distribute the agents throughout the entire body, even though the drugs are typically only needed at specific tissues. This often limits dosage and causes discomfort and harmful side‐effects. Significant research has examined nanoparticles (NPs) for use as targeted delivery vehicles for therapeutic cargo, however, major clinical success has been limited. Current work focuses mainly on liposomal and polymer‐based NPs, but emerging research is exploring the engineering of viral capsids as noninfectious protein‐based NPs—termed virus‐like particles (VLPs). This review covers the research that has been performed thus far and outlines the potential for these VLPs to become highly effective delivery vehicles that overcome the many challenges encountered for targeted delivery of therapeutic cargo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 1×
“As mentioned previously, targeted drug delivery by NPs must overcome multiple challenges (Table 1).(31) The ability to overcome these challenges must either be intrinsic or be imparted as the VLPs are prepared by: (a) loading the cargo inside the NP, and (b) functionalizing the NP to deliver its cargo primarily to the…”
BackgroundPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Lewis Phillips, G. D., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blättler, W. A., Lambert, J. M., Chari, R. V. J., Lutz, R. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1776 · Cited by 1,676
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,206
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Metal‐based nanoparticles and their toxicity assessment
Schrand, A. M., Rahman, M. F., Hussain, S. M., Schlager, J. J., Smith, D. A., & Syed, A. F. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.103 · Cited by 753
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Srinivasarao, M., Galliford, C. V., & Low, P. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4519 · Cited by 671
The Crystal Structure of the Human Hepatitis B Virus Capsid
Wynne, S. A., Crowther, R. A., & Leslie, A. G. W. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80009-5 · Cited by 667
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 527
Goldenberg, M. M. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88288-0 · Cited by 453
A virus-based single-enzyme nanoreactor
Comellas-Aragonès, M., Engelkamp, H., Claessen, V. I., Sommerdijk, N. A. J. M., Rowan, A. E., Christianen, P. C. M., Maan, J. C., Verduin, B. J. M., Cornelissen, J. J. L. M., & Nolte, R. J. M. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.299 · Cited by 431
Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T.-Y., & Pellois, J.-P. (2012) · Pharmaceuticals · doi:10.3390/ph5111177 · Cited by 384
Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles
Ashley, C. E., Carnes, E. C., Phillips, G. K., Durfee, P. N., Buley, M. D., Lino, C. A., Padilla, D. P., Phillips, B., Carter, M. B., Willman, C. L., et al. (2011) · ACS Nano · doi:10.1021/nn201397z · Cited by 350
Viral nanoparticles as tools for intravital vascular imaging
Lewis, J. D., Destito, G., Zijlstra, A., González, M. J., Quigley, J. P., Manchester, M., & Stuhlmann, H. (2006) · Nature Medicine · doi:10.1038/nm1368 · Cited by 337
Gupta, S. S., Kuzelka, J., Singh, P., Lewis, W. G., Manchester, M., & Finn, M. G. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050147l · Cited by 303
Applications of viral nanoparticles in medicine
Yildiz, I., Shukla, S., & Steinmetz, N. F. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.04.020 · Cited by 299
Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1777 · Cited by 286
Self‐Assembly and Cross‐Linking of Bionanoparticles at Liquid–Liquid Interfaces
Russell, J. T., Lin, Y., Böker, A., Su, L., Carl, P., Zettl, H., He, J., Sill, K., Tangirala, R., Emrick, T., et al. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462653 · Cited by 269
Nanoreactors by Programmed Enzyme Encapsulation Inside the Capsid of the Bacteriophage P22
Patterson, D. P., Prevelige, P. E., & Douglas, T. (2012) · ACS Nano · doi:10.1021/nn300545z · Cited by 262
Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo
Singh, P., Prasuhn, D., Yeh, R. M., Destito, G., Rae, C. S., Osborn, K., Finn, M. G., & Manchester, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.003 · Cited by 254
Encapsulation of an Enzyme Cascade within the Bacteriophage P22 Virus-Like Particle
Patterson, D. P., Schwarz, B., Waters, R. S., Gedeon, T., & Douglas, T. (2014) · ACS Chemical Biology · doi:10.1021/cb4006529 · Cited by 239
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Zhou, J., & Rossi, J. J. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.21 · Cited by 234
Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227
Folic Acid-Mediated Targeting of Cowpea Mosaic Virus Particles to Tumor Cells
Destito, G., Yeh, R., Rae, C. S., Finn, M. G., & Manchester, M. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.08.015 · Cited by 225
Viral Capsid DNA Aptamer Conjugates as Multivalent Cell-Targeting Vehicles
Tong, G. J., Hsiao, S. C., Carrico, Z. M., & Francis, M. B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903857f · Cited by 224
The crystal structure of bacteriophage Qβ at 3.5 å resolution
Golmohammadi, R., Fridborg, K., Bundule, M., Valegård, K., & Liljas, L. (1996) · Structure · doi:10.1016/s0969-2126(96)00060-3 · Cited by 215
Bioengineered protein-based nanocage for drug delivery
Lee, E. J., Lee, N. K., & Kim, I.-S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.002 · Cited by 215
Dual-Surface Modified Virus Capsids for Targeted Delivery of Photodynamic Agents to Cancer Cells
Stephanopoulos, N., Tong, G. J., Hsiao, S. C., & Francis, M. B. (2010) · ACS Nano · doi:10.1021/nn1014769 · Cited by 211
Packaging of a Polymer by a Viral Capsid: The Interplay between Polymer Length and Capsid Size
Hu, Y., Zandi, R., Anavitarte, A., Knobler, C. M., & Gelbart, W. M. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.117473 · Cited by 210
Prasuhn, Jr., Yeh, R. M., Obenaus, A., Manchester, M., & Finn, M. G. (2007) · Chem. Commun. · doi:10.1039/b615084e · Cited by 204
Controlled Encapsulation of Multiple Proteins in Virus Capsids
Minten, I. J., Hendriks, L. J. A., Nolte, R. J. M., & Cornelissen, J. J. L. M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907843s · Cited by 204
RNA‐Directed Packaging of Enzymes within Virus‐like Particles
Fiedler, J. D., Brown, S. D., Lau, J. L., & Finn, M. G. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005243 · Cited by 201
Kovacs, E. W., Hooker, J. M., Romanini, D. W., Holder, P. G., Berry, K. E., & Francis, M. B. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070006e · Cited by 196
Cadena-Nava, R. D., Comas-Garcia, M., Garmann, R. F., Rao, A. L. N., Knobler, C. M., & Gelbart, W. M. (2012) · Journal of Virology · doi:10.1128/jvi.06566-11 · Cited by 193
Casi, G., & Neri, D. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00457 · Cited by 189
Pillai, G. (2014) · SOJ Pharmacy & Pharmaceutical Sciences · doi:10.15226/2374-6866/1/2/00109 · Cited by 187
Functionalization of protein-based nanocages for drug delivery applications
Schoonen, L., & van Hest, J. C. M. (2014) · Nanoscale · doi:10.1039/c4nr00915k · Cited by 184
Patel, K. G., & Swartz, J. R. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100367u · Cited by 182
Self-citationEscherichia coli‐based cell‐free synthesis of virus‐like particles
Bundy, B. C., Franciszkowicz, M. J., & Swartz, J. R. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21716 · Cited by 179
Self-citationLucon, J., Qazi, S., Uchida, M., Bedwell, G. J., LaFrance, B., Prevelige, P. E., & Douglas, T. (2012) · Nature Chemistry · doi:10.1038/nchem.1442 · Cited by 178
Kaiser, C. R., Flenniken, M. L., Gillitzer, E., Harmsen, A. L., Harmsen, A. G., Jutila, M. A., Douglas, T., & Young, M. (2007) · PubMed · Cited by 178
Systemic trafficking of plant virus nanoparticles in mice via the oral route
Rae, C. S., Wei Khor, I., Wang, Q., Destito, G., Gonzalez, M. J., Singh, P., Thomas, D. M., Estrada, M. N., Powell, E., Finn, M. G., et al. (2005) · Virology · doi:10.1016/j.virol.2005.08.017 · Cited by 171
O'Neil, A., Reichhardt, C., Johnson, B., Prevelige, P. E., & Douglas, T. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102036 · Cited by 168
Chemical modification of a viral cage for multivalent presentation
Gillitzer, E., Willits, D., Young, M., & Douglas, T. (2002) · Chemical Communications · doi:10.1039/b207853h · Cited by 163
Porterfield, J. Z., Dhason, M. S., Loeb, D. D., Nassal, M., Stray, S. J., & Zlotnick, A. (2010) · Journal of Virology · doi:10.1128/jvi.00586-10 · Cited by 159
Shukla, S., Ablack, A. L., Wen, A. M., Lee, K. L., Lewis, J. D., & Steinmetz, N. F. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300240m · Cited by 158
Parent, K. N., Khayat, R., Tu, L. H., Suhanovsky, M. M., Cortines, J. R., Teschke, C. M., Johnson, J. E., & Baker, T. S. (2010) · Structure · doi:10.1016/j.str.2009.12.014 · Cited by 158
Brunel, F. M., Lewis, J. D., Destito, G., Steinmetz, N. F., Manchester, M., Stuhlmann, H., & Dawson, P. E. (2010) · Nano Letters · doi:10.1021/nl1002526 · Cited by 155
Emerging Technologies of Polymeric Nanoparticles in Cancer Drug Delivery
Brewer, E. C., Coleman, J., & Lowman, A. M. (2010) · Journal of Nanomaterials · doi:10.1155/2011/408675 · Cited by 145
MS2 Viruslike Particles: A Robust, Semisynthetic Targeted Drug Delivery Platform
Galaway, F. A., & Stockley, P. G. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3003368 · Cited by 143
Steinmetz, N. F., & Manchester, M. (2009) · Biomacromolecules · doi:10.1021/bm8012742 · Cited by 142
Lu, Y., Chan, W., Ko, B. Y., VanLang, C. C., & Swartz, J. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510533112 · Cited by 142
Self-citationBessa, J., Köpf, M., & Bachmann, M. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903949 · Cited by 137
Osmolyte-Mediated Encapsulation of Proteins inside MS2 Viral Capsids
Glasgow, J. E., Capehart, S. L., Francis, M. B., & Tullman‐Ercek, D. (2012) · ACS Nano · doi:10.1021/nn302183h · Cited by 137
Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds
Astronomo, R. D., Kaltgrad, E., Udit, A. K., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.012 · Cited by 132
Development of a microRNA delivery system based on bacteriophage MS2 virus‐like particles
Pan, Y., Zhang, Y., Jia, T., Zhang, K., Li, J., & Wang, L. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08512.x · Cited by 129
Aptamers for Targeted Drug Delivery
Ray, P., & White, R. R. (2010) · Pharmaceuticals · doi:10.3390/ph3061761 · Cited by 129
Peyret, H., Annick, G., Thuenemann, E. C., Blond, D., El-Turabi, A., Beales, L., Clarke, D. S., Gilbert, R. J. C., Fry, E. E., Stuart, D. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120751 · Cited by 128
Narang, A., Chang, R.-K., & Hussain, M. A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23691 · Cited by 122
Reengineering viruses and virus-like particles through chemical functionalization strategies
Smith, M. T., Hawes, A., & Bundy, B. C. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.01.011 · Cited by 118
A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches
Bruno, J. G. (2013) · Pharmaceuticals · doi:10.3390/ph6030340 · Cited by 118
Multivalent Display and Receptor‐Mediated Endocytosis of Transferrin on Virus‐Like Particles
Banerjee, D., Liu, A. P., Voss, N. R., Schmid, S. L., & Finn, M. G. (2010) · ChemBioChem · doi:10.1002/cbic.201000125 · Cited by 118
Patterson, D. P., Schwarz, B. H., El‐Boubbou, K., John van der, O. O. S. T., Prevelige, P. E., & Douglas, T. (2012) · Soft Matter · doi:10.1039/c2sm26485d · Cited by 115
Efficient disulfide bond formation in virus-like particles
Bundy, B. C., & Swartz, J. R. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.04.011 · Cited by 113
Self-citationAi, J., Keshel, S. H., Ghorbani, F., Ejazi, F., Biazar, E., Asefnejad, A., Pourshamsian, K., & Montazeri, M. (2011) · Journal of Nanomaterials · doi:10.1155/2011/123724 · Cited by 113
Steinmetz, N. F., Ablack, A. L., Hickey, J. L., Ablack, J., Manocha, B., Mymryk, J. S., Luyt, L. G., & Lewis, J. D. (2011) · Small · doi:10.1002/smll.201000435 · Cited by 112
Garmann, R. F., Comas‐García, M., Gopal, A., Knobler, C. M., & Gelbart, W. M. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.017 · Cited by 108
Plasma Clearance of Bacteriophage Qβ Particles as a Function of Surface Charge
Prasuhn, D. E., Singh, P. N. P., Strable, E., Brown, S. D., Manchester, M., & Finn, M. G. (2008) · Journal of the American Chemical Society · doi:10.1021/ja075937f · Cited by 104
MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice
Pan, Y., Jia, Zhang, Zhang, Zhang, Li, & Wang, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s37990 · Cited by 103
Reconstituted plant viral capsids can release genes to mammalian cells
Azizgolshani, O., Garmann, R. F., Cadena-Nava, R. D., Knobler, C. M., & Gelbart, W. M. (2013) · Virology · doi:10.1016/j.virol.2013.03.001 · Cited by 98
Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor
Pokorski, J. K., Hovlid, M. L., & Finn, M. G. (2011) · ChemBioChem · doi:10.1002/cbic.201100469 · Cited by 97
Glycan-Targeted Virus-like Nanoparticles for Photodynamic Therapy
Rhee, J., Baksh, M. M., Nycholat, C. M., Paulson, J. C., Kitagishi, H., & Finn, M. G. (2012) · Biomacromolecules · doi:10.1021/bm300578p · Cited by 96
PET Imaging and Biodistribution of Chemically Modified Bacteriophage MS2
Farkas, M. E., Aanei, I. L., Behrens, C. R., Tong, G. J., Murphy, S. T., O’Neil, J. P., & Francis, M. B. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3003754 · Cited by 95
Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System
Qazi, S., Miettinen, H. M., Wilkinson, R. A., McCoy, K., Douglas, T., & Wiedenheft, B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00822 · Cited by 88
Prel, A., Caval, V., Gayon, R., Ravassard, P., Duthoit, C. T., Payen, E., Maouche-Chretien, L., Crénéguy, A., Nguyen, T. H., Martin, N., et al. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2015.39 · Cited by 87
Wei, B., Wei, Y., Zhang, K., Wang, J., Xu, R., Zhan, S., Lin, G., Wang, W., Liu, M., Wang, L., et al. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.07.086 · Cited by 85
Engineered Mutations Change the Structure and Stability of a Virus-Like Particle
Fiedler, J. D., Higginson, C. J., Hovlid, M. L., Kislukhin, A. A., Castillejos, A. G., Manzenrieder, F., Campbell, M. G., Voss, N. R., Potter, C. S., Carragher, B. O., et al. (2012) · Biomacromolecules · doi:10.1021/bm300590x · Cited by 84
Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles
Hovlid, M. L., Lau, J. L., Breitenkamp, K., Higginson, C. J., Laufer, B., Manchester, M., & Finn, M. G. (2014) · ACS Nano · doi:10.1021/nn502043d · Cited by 84
Dhason, M. S., Wang, J. C., Hagan, M. F., & Zlotnick, A. (2012) · Virology · doi:10.1016/j.virol.2012.04.012 · Cited by 77
Controlled Integration of Polymers into Viral Capsids
Comellas-Aragonès, M., de la Escosura, A., Dirks, A. J., van der Ham, A., Fusté-Cuñé, A., Cornelissen, J. J. L. M., & Nolte, R. J. M. (2009) · Biomacromolecules · doi:10.1021/bm9007953 · Cited by 75
Speir, J. A., Bothner, B. B., Qu, C., Willits, D. A., Young, M., & Johnson, J. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3582-3591.2006 · Cited by 75
Anand, P., O’Neil, A., Lin, E. P.-Y., Douglas, T., & Holford, M. (2015) · Scientific Reports · doi:10.1038/srep12497 · Cited by 75
Predicting the Loading of Virus-Like Particles with Fluorescent Proteins
Rurup, W. F., Verbij, F. C., Koay, M. S. T., Blum, C., Subramaniam, V., & Cornelissen, J. J. L. M. (2013) · Biomacromolecules · doi:10.1021/bm4015792 · Cited by 70
Schwarz, B. H., Madden, P. J., Avera, J., Gordon, B., Larson, K., Miettinen, H. M., Uchida, M., LaFrance, B. J., Basu, G., Rynda‐Apple, A., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03360 · Cited by 70
van Iterson, M., Bervoets, S., de Meijer, E. J., Buermans, H. P. J., Hoen, P. A. C. ’., de Menezes, R. X., & Boer, J. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt525 · Cited by 69
Rapid Chemoselective Bioconjugation through Oxidative Coupling of Anilines and Aminophenols
Behrens, C. R., Hooker, J. M., Obermeyer, A. C., Romanini, D. W., Katz, E. M., & Francis, M. B. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2033298 · Cited by 64
Liposome surface functionalization based on different anchoring lipids via Staudinger ligation
Vabbilisetty, P., & Sun, X. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41721b · Cited by 63
Influence of Electrostatics on Small Molecule Flux through a Protein Nanoreactor
Glasgow, J. E., Asensio, M. A., Jakobson, C. M., Francis, M. B., & Tullman‐Ercek, D. (2015) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00037 · Cited by 63
Development of viral nanoparticles for efficient intracellular delivery
Wu, Z., Chen, K., Yıldız, İ., Dirksen, A., Fischer, R., Dawson, P. E., & Steinmetz, N. F. (2012) · Nanoscale · doi:10.1039/c2nr30366c · Cited by 61
Llauró, A., Luque, D., Edwards, E., Trus, B. L., Avera, J., Reguera, D., Douglas, T., de Pablo, P. J., & Castón, J. R. (2016) · Nanoscale · doi:10.1039/c6nr01007e · Cited by 61
Co-expression of RNA–protein complexes in Escherichia coli and applications to RNA biology
Ponchon, L., Catala, M., Seijo, B., Khouri, M. E., Dardel, F., Nonin‐Lecomte, S., & Tisné, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt576 · Cited by 58
Lagoutte, P., Mignon, C., Donnat, S., Stadthagen, G., Mast, J., Sodoyer, R., Lugari, A., & Werle, B. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.02.011 · Cited by 58
Guiding plant virus particles to integrin-displaying cells
Hovlid, M. L., Steinmetz, N. F., Laufer, B., Lau, J. L., Kuzelka, J., Wang, Q., Hyypiä, T., Nemerow, G. R., Kessler, H., Manchester, M., et al. (2012) · Nanoscale · doi:10.1039/c2nr30571b · Cited by 56
Lu, Y., Welsh, J. P., Chan, W. M., & Swartz, J. R. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24903 · Cited by 56
Self-citationGenome-free Viral Capsids as Carriers for Positron Emission Tomography Radiolabels
Hooker, J. M., O’Neil, J. P., Romanini, D. W., Taylor, S. E., & Francis, M. B. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0136-5 · Cited by 55
Engineering of Brome mosaic virus for biomedical applications
Yıldız, İ., Tsvetkova, I. B., Wen, A. M., Shukla, S., Hema, M., Dragnea, B. G., & Steinmetz, N. F. (2012) · RSC Advances · doi:10.1039/c2ra01376b · Cited by 55
Phelps, J. P., Dang, N., & Rasochová, L. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2006.12.008 · Cited by 48
Update on current and potential nanoparticle cancer therapies
Rink, J. S., Plebanek, M. P., Tripathy, S., & Thaxton, C. S. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000012 · Cited by 48
Millán, J. G., Brasch, M., Anaya‐Plaza, E., de la Escosura, A., Velders, A. H., Reinhoudt, D. N., Torres⊗, T., Koay, M. S. T., & Cornelissen, J. J. L. M. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.01.004 · Cited by 42
Using a Novel MicroRNA Delivery System to Inhibit Osteoclastogenesis
Yao, Y., Jia, T., Pan, Y., Gou, H., Li, Y., Sun, Y., Zhang, R., Zhang, K., Lin, G., Xie, J., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048337 · Cited by 42
Servid, A. E., Jordan, P. C., O’Neil, A., Prevelige, P. E., & Douglas, T. (2013) · Biomacromolecules · doi:10.1021/bm400796c · Cited by 41
Yin, Z., Dulaney, S. B., McKay, C. S., Baniel, C., Kaczanowska, K., Ramadan, S., Finn, M. G., & Huang, X. (2015) · ChemBioChem · doi:10.1002/cbic.201500499 · Cited by 39
Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform
O’Rourke, J. P., Peabody, D. S., & Chackerian, B. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.03.005 · Cited by 30
Francl, M. M. (2015) · Nature Chemistry · doi:10.1038/nchem.2426 · Cited by 29
Pomwised, R., Intamaso, U., Teintze, M., Young, M., & Pincus, S. H. (2016) · Vaccines · doi:10.3390/vaccines4020015 · Cited by 25
Crystal Structure and Proteomics Analysis of Empty Virus-like Particles of Cowpea Mosaic Virus
Huynh, N., Hesketh, E. L., Saxena, P., Meshcheriakova, Y., Ku, Y.-C., Hoang, L. T., Johnson, J. E., Ranson, N. A., Lomonossoff, G. P., & Reddy, V. S. (2016) · Structure · doi:10.1016/j.str.2016.02.011 · Cited by 24
Hommersom, C. A., Matt, B., van der Ham, A., Cornelissen, J. J. L. M., & Katsonis, N. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00505h · Cited by 23
Developing a Dissociative Nanocontainer for Peptide Drug Delivery
Kelly, P., Anand, P., Uvaydov, A., Chakravartula, S. V. S., Sherpa, C., Pires, E., O’Neil, A., Douglas, T., & Holford, M. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph121012543 · Cited by 21
Plevka, P., Tārs, K., & Liljas, L. (2009) · Protein Science · doi:10.1002/pro.184 · Cited by 21
Rumnieks, J., Ose, V., Tārs, K., Dišlers, A., Strods, A., Cielēns, I., & Renhofa, R. (2009) · Virology · doi:10.1016/j.virol.2009.06.023 · Cited by 12
Cited by
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.014 · Cited by 555
Protein Nanoparticles: Promising Platforms for Drug Delivery Applications
Jain, A., Singh, S. K., Arya, S. K., Kundu, S. C., & Kapoor, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01098 · Cited by 308
Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting
Liu, J. F., Jang, B., Issadore, D., & Tsourkas, A. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1571 · Cited by 265
Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
Ho, W., Gao, M., Li, F., Li, Z., Zhang, X., & Xu, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001812 · Cited by 261
Metadata
- Authors
- Rohovie, M. J., Nagasawa, M., & Swartz, J. R.
- Venue
- Bioengineering & Translational Medicine
- Publisher
- Wiley
- Published
- 2017-01-19
- Volume
- 2
- Issue
- 1
- Pages
- 43-57
- ISSN
- 2380-6761 (ISSN-L)
- OpenAlex
- W2562690513
- Cited by
- 340
- References
- 118
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.